ECSP13012798A - Método para inhibir patógenos usando una composición nutricional - Google Patents

Método para inhibir patógenos usando una composición nutricional

Info

Publication number
ECSP13012798A
ECSP13012798A ECSP13012798A ECSP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A EC SP13012798 A ECSP13012798 A EC SP13012798A
Authority
EC
Ecuador
Prior art keywords
nutritional composition
inhibiting pathogens
inhibiting
human
source
Prior art date
Application number
Other languages
English (en)
Inventor
Robert J Mcmahon
Anja Wittke
Cecilia Munoz
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/980,813 external-priority patent/US8648036B2/en
Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of ECSP13012798A publication Critical patent/ECSP13012798A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un método para inhibir un mecanismo bacteriano invasivo o de adhesión que involucra el administrar a un humano una composición nutricional que incluye un lípido o grasa; una fuente de proteína; una composición prebiótica; y al menos aproximadamente 10 mg/100 kCal de lactoferrinas producidas por una fuente no humana.
ECSP13012798 2010-12-29 2013-07-29 Método para inhibir patógenos usando una composición nutricional ECSP13012798A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/980,813 US8648036B2 (en) 2010-12-29 2010-12-29 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 US20120171163A1 (en) 2010-12-29 2010-12-29 Method for inhibiting a bacterial invasive mechanism using a nutritional composition

Publications (1)

Publication Number Publication Date
ECSP13012798A true ECSP13012798A (es) 2013-09-30

Family

ID=45496273

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012798 ECSP13012798A (es) 2010-12-29 2013-07-29 Método para inhibir patógenos usando una composición nutricional

Country Status (13)

Country Link
EP (1) EP2658388A2 (es)
CN (1) CN103327828B (es)
BR (1) BR112013011642B1 (es)
CA (1) CA2822892C (es)
EC (1) ECSP13012798A (es)
MX (1) MX2013006094A (es)
MY (1) MY174494A (es)
PE (1) PE20141192A1 (es)
PH (1) PH12013500916A1 (es)
RU (1) RU2013128920A (es)
SG (2) SG190781A1 (es)
TW (1) TWI626893B (es)
WO (1) WO2012091946A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8968722B2 (en) 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
WO2014099134A1 (en) * 2012-12-18 2014-06-26 Mjn U.S. Holdings Llc Milk-based nutritional compositions containing lactoferrin and uses thereof
US20140271978A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) * 2017-09-10 2020-09-03 Technion Research & Development Foundation Limited Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) * 2022-05-13 2023-11-15 Lintbells Ltd Methods and processes for manufacture of a topically adherent selective bactericide
CN120051217A (zh) 2022-09-14 2025-05-27 N·V·努特里奇亚 营养组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
CA2101274C (en) 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
EP0744901B1 (en) 1994-02-16 2001-12-05 Pharming Intellectual Property BV Isolation of lactoferrin from milk
EP1480524B1 (en) 2002-03-07 2013-04-17 Upfront Chromatography A/S A process of isolating lactoferrin
US20070191264A1 (en) * 2005-05-05 2007-08-16 Bristol-Myers Squibb Company, A Delaware Corporation Methods for inhibiting the growth of bacteria
CN101247823A (zh) * 2005-05-05 2008-08-20 布里斯托尔-迈尔斯斯奎布公司 牛乳铁蛋白在制备抑制细菌生长的药物中的用途
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
WO2008047391A1 (en) * 2006-10-17 2008-04-24 S.I.F.Fr.A. Farmaceutici Srl Nutriceutic composition comprising lactoferrin and proteasic probiotics
BRPI0819445A2 (pt) * 2007-11-26 2015-12-22 Nestec Sa sistema de nutrição para recém-nascidos adaptado à idade
ITRM20080163A1 (it) * 2008-03-26 2009-09-27 Maurizio Acri Uso della lattoferrina per la prevenzione delle sepsi neonatali in neonati prematuri
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
EP2493336A1 (en) * 2009-10-29 2012-09-05 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof

Also Published As

Publication number Publication date
PH12013500916A1 (en) 2024-06-03
EP2658388A2 (en) 2013-11-06
CA2822892A1 (en) 2012-07-05
CN103327828A (zh) 2013-09-25
CN103327828B (zh) 2016-05-11
PE20141192A1 (es) 2014-10-01
TWI626893B (zh) 2018-06-21
HK1189456A1 (zh) 2014-06-13
MY174494A (en) 2020-04-23
TW201238503A (en) 2012-10-01
BR112013011642B1 (pt) 2020-04-07
WO2012091946A2 (en) 2012-07-05
WO2012091946A3 (en) 2012-09-07
SG10201508194RA (en) 2015-11-27
SG190781A1 (en) 2013-07-31
BR112013011642A2 (pt) 2016-07-12
RU2013128920A (ru) 2015-02-10
CA2822892C (en) 2020-04-28
MX2013006094A (es) 2013-07-03

Similar Documents

Publication Publication Date Title
ECSP13012798A (es) Método para inhibir patógenos usando una composición nutricional
MX2015007933A (es) Oligosacaridos de leche humana para mejorar sintomas de estres.
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
BR112013025974A2 (pt) produto de alimentação compreendendo camadas diferentes
BR112012032816A2 (pt) composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
GB201101459D0 (en) Novel compounds and thier effects on fedding behaviour
BR112015029987A8 (pt) Beta-caseína a2 e a prevenção de inflamação do intestino
BRPI0817156A8 (pt) Matéria gorda láctea de vaca, método para obter a matéria gorda láctea de vaca e composição alimentar
BR112014027820A2 (pt) controle dietário de doença celíaca e alergias alimentares
WO2013028555A3 (en) Methods for weight loss and ketogenic compositions
MX382215B (es) Composiciones para usarse en enfermedades que involucran la acumulación de grasa en los tejidos.
BR112014015354A8 (pt) composição de extratos enriquecidos com elagitaninos no bem-estar sexual
ECSP13012799A (es) Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones
BR112013027474A2 (pt) composições que melhoram a palatabilidade
ZA201404537B (en) Method and composition for increasing the proportion of dietary ingredients that are resistant to degradation by ruminal microorganisms
BR112014007328A2 (pt) composições de alimentos mastigáveis
WO2010119424A3 (fr) Composition destinee a la regulation du metabolisme des lipides
PE20151498A1 (es) Composicion nutricional para promover la saciedad
MX2014001767A (es) Metodos para reducir sintomas o condiciones causados por estres.
BR112014003545A2 (pt) método para transformar uma refeição
BR112012021710A2 (pt) marinadas para carnes e frutos do mar contendo metabolismos naturais.
PE20141022A1 (es) Composiciones y procedimientos para la administracion de nutrientes